To further investigate our speculation that RGC32 may regulate EMT through the Smad/Sip1 signaling pathway in CRC cells, we used siRNAs specifically targeting Sip1 to knock down endogenous Sip1 in SW620 cells (Fig. 5A,B). The gene discussed is RGCC; the disease is colorectal carcinoma.